Testing a new creatinine device for kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new handheld device that checks creatinine levels from a small drop of blood. If you have kidney disease or abnormal creatinine, this test could give you faster results without sending blood to a lab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have abnormal creatinine levels or suspected kidney disease.
- You must be 18 years old or older.
- You must be willing to sign an informed consent form.
- Your HCT (hematocrit, or the percentage of red blood cells in your blood) must be between 25% and 65%.
- You must not have severe mental illness, and you must be able to read and write in English.
- You cannot have used this or a similar self-monitoring device before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure kidney function using harmless electrical signals instead of needles. It may help people with chronic kidney disease avoid frequent blood draws.
This study tests a connected urine test strip (a small device that checks your urine at home) to help doctors assess what you eat and improve your diet. It's for people with advanced chronic kidney disease who need help managing their nutrition.
This trial tests if a portable ECG device can help detect high potassium levels early in people with moderate to severe chronic kidney disease. It aims to make monitoring easier without frequent blood tests.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
This study tests a new portable device that measures potassium and ionized calcium levels from a finger-stick blood sample. It may help doctors get faster results for people who need regular monitoring.
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.